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What is already known about this topic? 
 Urinary tract (UT) anomalies are among the most frequent congenital anomalies. 
What does this study add? 
 After the introduction of the prenatal screening program an increase in prevalence of anomalies 
of the collecting system was observed, .  
 Due to the high uptake of the second trimester anomaly scan and improved skills of the 
sonographers, more UT anomalies are detected prenatally that would otherwise remain 




Objective: To describe prevalence, time of diagnosis and type of birth in children and fetuses with 
urinary tract (UT) anomalies after the introduction of the anomaly scan in the Netherlands in 2007.  
Methods: We selected, from a population-based congenital anomaly registry, children and fetuses 
with UT anomalies born between 2008-2014. Cases were defined according to type of UT anomaly 
and whether isolated or with associated anomalies. Information was collected on time of diagnosis 
and type of birth.  
Results: We included 487 cases. Total prevalence increased from 34.0 in 2008 to 42.3 per 10,000 
births in 2014, mainly by an increase in anomalies of the collecting system. Almost 70% presented as 
isolated. Anomalies of the renal parenchyma were more often associated with genetic or other 
anomalies (47.3%) than anomalies of the collecting system (19.0%). The proportion of prenatally 
diagnosed cases increased from 59.3 % in 2008 to 80.9% in 2014. Termination of pregnancy occurred 
in 14.8%, of which the majority were UT anomalies associated with a genetic disorder or other 
anomalies.  
Conclusion: In the period after the introduction of the anomaly scan we observed an increasing 
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Introduction 
Renal urinary tract (UT) anomalies are among the most common congenital anomalies. The average 
European prevalence was 32.8/10,000 births over the period 2010-2014.1 UT anomalies represent a 
broad phenotypic spectrum, ranging from renal agenesis, cystic kidney diseases, hydronephrosis and 
lower-urinary tract obstructions, all with a wide range in severity. Some anomalies are incompatible 
with life, such as bilateral renal agenesis, while other anomalies are mild and may remain 
undetected if not diagnosed by ultrasound. Risk factors for UT anomalies include genetic and non-
genetic factors2, such as maternal obesity3 and fertility treatment,4 whereas the use of folic acid is 
reported to reduce the risk.5 UT anomalies are more commonly observed in male fetuses.6 Because 
congenital UT anomalies are the cause of 30 to 40 percent of cases of end-stage renal disease, 
especially in young children, early diagnosis is important to start therapy and minimize renal 
damage.7 
Before the introduction of the prenatal screening program in the Netherlands in 2007, ultrasound 
scans were only performed on clinical indication (suspected poor or excessive fetal growth, including 
oligo- or polyhydramnios, positive family history for congenital anomalies, use of teratogens, 
diabetes etc.) or for keepsake. In 2007, a national prenatal screening program was introduced in the 
Netherlands, including the combined first trimester screening for trisomy 21, 13 and 18 and an 
anomaly scan between 18-22 weeks of gestation.8 The latter is offered free of charge to all pregnant 
women with an uptake of more than 90%. When an anomaly is suspected, the pregnant woman is 
referred to a Fetal Medicine Unit, a tertiary center for prenatal diagnosis where an advanced 
ultrasound scan is performed by a specialist and, if appropriate, additional genetic testing is offered.  
The aim of this study was to examine whether in the period after the introduction of the prenatal 
screening program there were specific trends in the prevalence of UT anomalies, clinical 
presentation, time of diagnosis and outcome of pregnancies in which the fetus was affected with an 
anomaly of the urinary tract.  
 
Methods 
We conducted a study within Eurocat Northern Netherlands, a population-based congenital anomaly 
registry covering the three Northern provinces of the Netherlands (approximately 10% of all births in 
the Netherlands). Cases are identified by active case ascertainment, using multiple sources including 
hospital files, prenatal diagnosis reports and post mortem reports. Cases are registered in the 
database after parental consent. For cases with a delivery date in 2010 and beyond, basic 
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information is registered (anomalies, type of birth, time of diagnosis), if parents do not answer to a 
second request for consent. Information on these so called ‘non-responders’ is registered to be able 
to calculate prevalence rates. There is no lower gestational age limit for registration, so early 
terminations for fetal anomalies and fetal deaths are included. The upper age limit for inclusion is 10 
years. Cases are coded using the ICD10-BPA classification system9 by trained registry staff. 
We selected from the database cases with a major anomaly of the urinary tract (ICD10 code within 
range Q60-Q64) and with an end of pregnancy date (birth, miscarriage or termination of pregnancy) 
between January 1, 2008 and December 31, 2014. 
Since there are many different types of anomalies of the urinary tract, we categorized cases into 4 
groups: malformations of the renal parenchyma, anomalies of the urinary collecting system, 
abnormal embryonic migration of kidneys and other UT anomalies and combinations of UT 
anomalies (table 1). 10The categorization was based on the primary UT anomaly. If a child had for 
instance renal dysplasia developing as consequence of an obstruction, the anomaly was classified as 
obstruction and categorized under ‘anomalies of the urinary collecting system’.  
[insert table 1 here] 
For each case we included information on sex, clinical presentation (isolated, part of a genetic 
condition or syndrome, or associated with multiple congenital anomalies (MCA)), time point the UT 
anomaly was detected (prenatally versus postnatally), and the status at birth (live birth (LB), still 
birth (SB), spontaneous abortion (SA), termination of pregnancy for fetal anomaly (TOP)). 
Analyses were performed in IBM SPSS Statistics for Windows, version 23.0 (Armonk, NY: IBM Corp.). 
Differences between UT anomaly categories were examined using the X2 test. Trends in prevalence 
were examined for the period 2010-2014 which included the ‘non-responders’, using the X2 test for 
trend. Trends in prenatal detection and birth types were examined for the whole period (2008-2010) 
since the denominator is all UT anomalies registered in the Eurocat database and the non-response 
should not be biased to certain UT anomalies. A p-value <0.05 was considered to be statistically 
significant. This study was done with anonymised patient data and therefore ethics committee 
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Results 
Between 2008 and 2014, 119,297 births were monitored in the Eurocat Northern Netherlands region 
and 487 fetuses and children were registered with a major anomaly of the urinary tract. The majority 
of these cases had an anomaly of the collecting system (n=302, 62.0%), whereas only 27.7% (n=135) 
had an anomaly of the renal parenchyma. In the supplementary table the specific anomalies per 
category are presented. The majority of cases were in male fetuses (n=330, 67.8%). The total 
prevalence was 40.8 per 10,000 births and increased from 34.0 per 10,000 births in 2008 to 42.3 per 
10,000 births in 2014(Figure 1). This increase was mainly attributable to anomalies of the collecting 
system which increased from 19.5 to 29.9 per 10,000 births in the same period. Trend analyses over 
the period 2010-2014 (which included the ‘non-responders’) showed a non-significant increase for 
all UT anomalies (p=0.062) and a significant increase in anomalies of the collecting system (p=0.048). 
There was no such trend observed for the other types of UT anomalies.  
[insert figure 1 here] 
Most UT anomalies presented as isolated, 69.6% (n=339). Whereas 16.4% (n=80) presented as part 
of a known genetic condition or syndrome, 14.0% (n=68) were associated with other major 
anomalies. Most frequent genetic conditions, associations or syndromes included VACTERL/VATER 
(n=8), Meckel-Gruber (n=7), trisomy 18 (n=7), limb body wall complex (n=6), Omphalocele-Estrophy-
Imperforate Anus – Spinal defects complex (OEIS complex; n=5), autosomal dominant polycystic 
kidney disease (n=3), trisomy 21 (n=3) and Turner syndrome (n=3). Anomalies of the collecting 
system presented most frequently as isolated (247/302, 81.8%), whereas 37.0% (10/27) of the cases 
with a combination of UT anomalies had a genetic background or were part of a syndrome.  
In total, 72.3% (n=352) of the UT anomalies were detected prenatally, with an increase from 59.3% 
in 2008 to 80.9% in 2014 (X2 for trend p<0.001, figure 2). The prenatal detection of anomalies of the 
renal parenchyma was 76.1% over the total period and fluctuated between 60.0% (in 2014) and 
90.0% (in 2010) (X2 for trend p=0.581, figure 2). Prenatal detection of cases with an anomaly of the 
collecting system was 70.4% over the study period and increased from 55.9% in 2008 to 81.3% in 
2014 (X2 for trend p<0.001, figure 2). For specific UT anomalies of the renal parenchyma and 
collecting system the prenatal detection varied between 0% for epispadias to over 90% for 
mulcticystic dysplastic kidney, ureteropelvic junction stenosis, stenosis of urethra or bladder neck 
and absence of bladder and urethra (Supplementary table). The prenatal detection rates for 
migration anomalies and multiple anomalies were 65% and 85% respectively over the total period.  
[insert figure 2 here] 
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There was a significant difference in prenatal detection according to the different clinical 
presentations of UT anomalies. The proportion of prenatally detected UT anomalies was highest 
among cases presenting as isolated UT anomalies (79.9%, n=270). Of the UT anomalies that were 
part of a syndrome or genetic condition or of MCA prenatal detection occurred in 62.5% (n=50) and 
47.1% (n=32), respectively (p<0.001). The timing of prenatal detection varied according to the 
different UT categories. Over the total period, 17% (n=59) of the prenatally detected UT anomalies 
were detected after 22 weeks gestation, these were mainly anomalies of the collecting system 
(n=46). 
The vast majority of fetuses with a UT anomaly were live births, 81.9% (n=399). Terminations of 
pregnancy and intra-uterine deaths occurred in 14.8% (n=72) and 3.3% (n=16), respectively. No 
trend in status at birth was observed over the study period. The latter however differed by clinical 
presentation and UT category (Table 2). In isolated UT anomalies or UT anomalies associated with a 
genetic condition or syndrome, live births occurred in 92.6% and 55.0%, respectively. The highest 
proportion of pregnancy terminations was observed in UT anomalies associated with a genetic 
condition or syndrome (41.3%). Since anomalies of the collecting system present most frequently as 
isolated, 91.4% of the cases with an anomaly of the collecting system were live born, while in cases 
with multiple UT anomalies fetal deaths (14.8%) and terminations of pregnancy (33.3%) were more 
frequent. 
[insert table 2 here] 
 
Discussion 
This study is the first to report on the prenatal diagnosis of UT anomalies after the introduction of a 
prenatal screening program. The results show an increasing trend in the proportion of prenatally 
detected UT anomalies, in particular for anomalies of the collecting system,  between 2008-2014. 
The majority of fetuses with an UT anomaly are live births; termination of pregnancy is chosen 
mainly when the UT anomaly is part of a genetic condition or syndrome or when it is part of a more 
severe spectrum (more than 1 type of UT anomaly present).  
We observed a non-significant increase in prevalence of UT anomalies of any kind and a significant 
increase in anomalies of the collecting system. The prevalence of UT anomalies in our study is higher 
than the European prevalence of 32.8 per 10,000 births reported in the EUROCAT network over 
2010-2014.1 There is a significant variation in prevalence of UT anomalies among (European) regions, 
with prevalence rates ranging between 12 and 71 per 10,000 births. Several non-genetic risk factors, 
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such as maternal diabetes, obesity and subfertility 3,4,11 have been identified that may explain in part 
the variations and trends that are observed in prevalence of (specific types of) UT anomalies. It 
remains unclear whether folic acid has a protective effect 5or increases the risk 4for (specific) urinary 
tract anomalies.  
Other studies have found that the prevalence of UT anomalies was affected by the availability of 
prenatal screening and ultrasound services. An increase in kidney anomalies, observed in Denmark 
between 2007 and 2012, was most likely due to an increase in completeness of registration and an 
improved (prenatal) diagnosis because of better diagnostic sensitivity of ultrasound.12 Garne et al. 
found in an European cohort study on hydronephrosis, that the availability of prenatal screening  
serviceswas related to the variability in prevalence. If there was no standard prenatal screening, the 
prevalence of congenital hydronephrosis was in general lower.13  
The increasing prevalence in anomalies of the collecting system in our study is most likely also the 
result of improved prenatal diagnosis due to the high uptake of the second trimester anomaly scan 
and improved skills of the sonographers. The prenatal screening program was swiftly introduced in 
2007 and many sonographers were trained at that time to perform the anomaly scan. The uptake of 
the anomaly scan was over 90% during the study period and did not increase in a substantial way. 
During the anomaly scan, a complete fetal anatomy survey is carried out, including the urinary 
system. The sonographer investigates the bladder (size, filling), presence of both kidneys, 
echogenicity of renal parenchyma and diameter of the pyela. As a consequence, a large majority of 
the UT anomalies are detected prenatally, except for anomalies that are difficult to visualize on US 
such as epispadias, vesico-uretero-renal reflux and posterior valves. Detection on US of enlarged 
pyela or hydroneprhosis may have led to an improved prenatal diagnosis of the underlying primary 
obstructive UT anomaly. In the period before the introduction of the prenatal screening 
program(2000-2006), the prevalence of UT anomalies was much lower in the Northern Netherlands 
(24.6 per 10,000 births ) compared to the prevalence thereafter (40.8 per 10,000 births in 2008-
2014).14 The higher prevalence rate found in this study supports the conclusion that the anomaly 
scan has led to more UT anomaly diagnoses.  
Although the prenatal detection rate increased during the study period to over 80%, no increase in 
termination of pregnancies was observed in our cohort. Our results are in line with other studies 
that documented high prenatal detection rates and relatively low termination rates. In a European 
study on multicystic dysplastic kidney (MCDK) in children born between 1997-2006, the prenatal 
detection rate was 88%. The choice for TOP was associated with the severity of MCDK, with higher 
rates in bilaterally affected cases or when associated anomalies were present. The authors 
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concluded that good prenatal detection can potentially inflate the prevalence rates, since some 
MCDK cases may involute postnatally, making a postnatal diagnosis impossible.15  
The decision of a couple to terminate the pregnancy depends greatly on the long-term prognosis. In 
some instances, during the course of the pregnancy, the findings on ultrasound may normalize and 
the child may have an excellent prognosis. In a prospective cohort of 115 patients with prenatally 
diagnosed UT anomalies, in particular children with a prenatal isolated unilateral or bilateral 
hydronephrosis had a favorable outcome. Oligohydramnios and postnatal bilateral anomalies are 
risk factors for unfavorable outcome (such as need for surgery or persistent renal anomalies with 
impaired renal function).16 In another study on 284 fetuses affected with a lower urinary tract 
obstruction and delivered between 1995-2007 in the West Midlands (England) a prenatal diagnosis 
rate of 51% was observed in all cases and somewhat higher in complex cases, compared to isolated 
cases. TOP was performed in 41% of complex cases and in 19% of isolated cases.17 These proportions 
are comparable with our study where TOP was chosen in 41% of cases with a genetic condition or 
syndrome diagnosis and 33% of the MCA cases. In general, TOP is associated with more severe types 
of UT anomalies. 
Anomalies of the collecting system represented the largest group in our study. This group includes 
primary hydronephrosis, which is a common obstructive anomaly, but also one of the UT anomalies 
that may have a favorable prognosis. In a recent study in one Dutch hospital, 24% of the children 
who were prenatally diagnosed with hydronephrosis were not confirmed postnatally or had mild 
dilatation without clinical consequences and only 19% developed complications (recurrent UT 
infections or pyelonephritis).18 
We performed a population-based cohort study, using data from a high quality registry for 
congenital anomalies. For each case there was detailed information available on UT- and possible 
additional anomalies, coded by trained registry staff. When performed, information from genetic 
tests was available. Therefore, we were able to classify the cases very precisely according to clinical 
presentation. Another strength is that we had detailed information on the time of detection and 
type of birth for each case. Since Eurocat only collects data on fetuses and infants with an anomaly, 
we were not able to include fetuses where an UT anomaly was suspected prenatally, but had 
resolved during pregnancy. However, it was not the aim of our study to evaluate the prognosis and 
outcome of prenatally detected UT anomalies. The registry uses multiple sources for case-finding. 
Although the registry tries to capture all the cases with a congenital (UT) anomaly, the registration 
may not be complete, due to non-consent of the parents. Approximately 7% of the parents do not 
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give consent for registration. Also, it may take some time to capture all the cases through active 
case-finding. Therefore, the most recent years may be less complete.  
In conclusion, after the introduction of the prenatal screening program we observed a non-
significantly increased prevalence of all UT anomalies and a significant increase in the prevalence of 
anomalies of the collecting system Currently over 80% of the UT anomalies are detected prenatally. 
Some of these anomalies might have remained undetected without anomaly scan, because of no or 
limited clinical consequences and may cause (unnecessary) anxiety for the future parents. Although 
more UT anomalies were prenatally diagnosed, no increase in termination of pregnancies was 
observed. It is important to improve information on follow-up of children prenatally diagnosed with 
UT anomalies to provide parents with correct information on the long-term prognosis.  
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Figure 1  Total annual prevalence of urinary tract anomalies per 10,000 births, for all UT 
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Figure 2  Prenatal detection of urinary tract anomalies in the Northern Netherlands between 
2008 and 2014, for all UT anomalies and for anomalies of the renal parenchyma and anomalies of 
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Table 1 Categorization of urinary tract anomalies according to the primary UT anomaly. 
Category UT anomalies included 
I Malformations of the renal 
parenchyma 
renal agenesis, renal hypoplasia, multicystic dysplastic kidney, cystic 
kidney, polycystic kidney, renal dypsplasia, dysplastic kidney in 
Meckel Gruber syndrome 
II Anomalies of the urinary 
collecting system  
hydronephrosis (end stage of obstructive anomalies), ureteropelvic 
junction stenosis, megaloureter, hydroureter, duplication of ureter, 
vesico-uretero-renal reflux, epispadias, exstrophy of urinary bladder, 
OEIS complex, (posterior) urethral valves,  stenosis, atresia of 
urethra and bladder neck, absence of bladder and urethra 
III Abnormal embryonic migration 
of kidneys and other UT 
anomalies 
pelvic kidney, horse shoe kidney, other malformations of urinary 
system 
IV Combination of UT anomalies Presence of at least two types of UT anomalies,  both considered to 
be primary anomalies and belonging to at least two categories  
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Table 2 Type of birth according to category of urinary tract anomalies and according to clinical 
presentation 
 
Type of birth 
 
Live births Fetal deaths 
Termination of 
pregnancy for fetal 
anomaly 
 
N % N % N % 
Category of UT anomaly             
anomalies of renal parenchym 94 69.6% 4 3.0% 37 27.4% 
anomalies of collecting system 276 91.4% 6 2.0% 20 6.6% 
anomalies of renal migration and other 15 65.2% 2 8.7% 6 26.1% 
multiple renal anomalies 14 51.9% 4 14.8% 9 33.3% 
Clinical presentation             
isolated 314 92.6% 6 1.8% 19 5.6% 
genetic/syndromic/sequence 44 55.0% 3 3.8% 33 41.3% 
MCA 41 60.3% 7 10.3% 20 29.4% 
Total 399 81.9% 16 3.3% 72 14.8% 
Abbreviations: UT=urinary tract,  MCA=multiple  congenital anomalies 
 
 
